These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 35371048)
1. The Insider: Impact of the Gut Microbiota on Cancer Immunity and Response to Therapies in Multiple Myeloma. Brevi A; Cogrossi LL; Lorenzoni M; Mattorre B; Bellone M Front Immunol; 2022; 13():845422. PubMed ID: 35371048 [TBL] [Abstract][Full Text] [Related]
2. Risk Stratification of Precursors to Multiple Myeloma in 2020. Chudasama R; Barth P R I Med J (2013); 2020 Apr; 103(3):46-47. PubMed ID: 32236162 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis and Management of Monoclonal Gammopathy and Smoldering Multiple Myeloma. Schmidt T; Callander N J Natl Compr Canc Netw; 2020 Dec; 18(12):1720-1729. PubMed ID: 33347744 [TBL] [Abstract][Full Text] [Related]
4. Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). Ho M; Patel A; Goh CY; Moscvin M; Zhang L; Bianchi G Leukemia; 2020 Dec; 34(12):3111-3125. PubMed ID: 33046818 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management. Maciocia N; Wechalekar A; Yong K Hematol Oncol; 2017 Dec; 35(4):432-439. PubMed ID: 27804161 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal gammopathies of unknown significance and smoldering myeloma: Assessment and management of the elderly patients. González-Calle V; Mateos MV Eur J Intern Med; 2018 Dec; 58():57-63. PubMed ID: 29907380 [TBL] [Abstract][Full Text] [Related]
7. The Role of T Cell Immunity in Monoclonal Gammopathy and Multiple Myeloma: From Immunopathogenesis to Novel Therapeutic Approaches. Lagreca I; Riva G; Nasillo V; Barozzi P; Castelli I; Basso S; Bettelli F; Giusti D; Cuoghi A; Bresciani P; Messerotti A; Gilioli A; Pioli V; Colasante C; Vallerini D; Paolini A; Maccaferri M; Donatelli F; Forghieri F; Morselli M; Colaci E; Leonardi G; Marasca R; Potenza L; Manfredini R; Tagliafico E; Trenti T; Comoli P; Luppi M Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563634 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. van de Donk NW; Mutis T; Poddighe PJ; Lokhorst HM; Zweegman S Int J Lab Hematol; 2016 May; 38 Suppl 1():110-22. PubMed ID: 27161311 [TBL] [Abstract][Full Text] [Related]
10. MGUS and Smoldering Multiple Myeloma: Diagnosis and Epidemiology. Mateos MV; Landgren O Cancer Treat Res; 2016; 169():3-12. PubMed ID: 27696254 [TBL] [Abstract][Full Text] [Related]
11. The yin-yang effects of immunity: From monoclonal gammopathy of undetermined significance to multiple myeloma. Yi Z; Ma T; Liu J; Tie W; Li Y; Bai J; Li L; Zhang L Front Immunol; 2022; 13():925266. PubMed ID: 35958625 [TBL] [Abstract][Full Text] [Related]
12. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution. Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies. Korde N; Kristinsson SY; Landgren O Blood; 2011 May; 117(21):5573-81. PubMed ID: 21441462 [TBL] [Abstract][Full Text] [Related]
14. Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic Disease. Isola I; Brasó-Maristany F; Moreno DF; Mena MP; Oliver-Calders A; Paré L; Rodríguez-Lobato LG; Martin-Antonio B; Cibeira MT; Bladé J; Rosiñol L; Prat A; Lozano E; Fernández de Larrea C Front Immunol; 2021; 12():792609. PubMed ID: 34880879 [TBL] [Abstract][Full Text] [Related]